-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Elanco Animal Health, Raises Price Target to $30

Benzinga·02/24/2026 20:16:08
Listen to the news
Leerink Partners analyst Daniel Clark maintains Elanco Animal Health (NYSE:ELAN) with a Outperform and raises the price target from $26 to $30.